131 related articles for article (PubMed ID: 21681107)
1. The safety of electroconvulsive therapy in patients with prolonged QTc intervals on the electrocardiogram.
Pullen SJ; Rasmussen KG; Angstman ER; Rivera F; Mueller PS
J ECT; 2011 Sep; 27(3):192-200. PubMed ID: 21681107
[TBL] [Abstract][Full Text] [Related]
2. QT dispersion and rate-corrected QT dispersion during electroconvulsive therapy in elderly patients.
Yamaguchi S; Nagao M; Ikeda T; Fukagawa D; Kimura Y; Kitajima T; Minami J
J ECT; 2011 Sep; 27(3):183-8. PubMed ID: 21865956
[TBL] [Abstract][Full Text] [Related]
3. Assessment of QT interval and QT dispersion during electroconvulsive therapy using computerized measurements.
Tezuka N; Egawa H; Fukagawa D; Yamaguchi S; Hamaguchi S; Kitajima T; Minami J
J ECT; 2010 Mar; 26(1):41-6. PubMed ID: 20190602
[TBL] [Abstract][Full Text] [Related]
4. Prolongation of QT interval induced by electroconvulsive therapy is attenuated by landiolol.
Matsura M; Fujiwara Y; Ito H; Kandatsu N; Kato N; Harada J; Komatsu T
J ECT; 2010 Mar; 26(1):37-40. PubMed ID: 20190601
[TBL] [Abstract][Full Text] [Related]
5. QTc dispersion in patients referred for electroconvulsive therapy.
Dodd ML; Dolenc TJ; Karpyak VM; Rasmussen KG
J ECT; 2008 Jun; 24(2):131-3. PubMed ID: 18580556
[TBL] [Abstract][Full Text] [Related]
6. Effects of propofol or etomidate on QT interval during electroconvulsive therapy.
Erdil F; Demirbilek S; Begec Z; Ozturk E; Ersoy MO
J ECT; 2009 Sep; 25(3):174-7. PubMed ID: 19225403
[TBL] [Abstract][Full Text] [Related]
7. Is prolongation of corrected QT interval associated with seizures induced by electroconvulsive therapy reduced by atropine sulfate?
Suzuki Y; Miyajima M; Ohta K; Yoshida N; Omoya R; Fujiwara M; Watanabe T; Okumura M; Yamazaki H; Shintaku M; Murata I; Ozaki S; Sasaki T; Nakamura M; Suwa H; Sasano T; Kawara T; Matsuura M; Matsushima E
Pacing Clin Electrophysiol; 2017 Nov; 40(11):1246-1253. PubMed ID: 28862317
[TBL] [Abstract][Full Text] [Related]
8. Alterations in QT dispersion in medicated schizophrenia patients following electroconvulsive therapy.
Nahshoni E; Manor N; Bar F; Stryjer R; Zalsman G; Weizman A
Eur Neuropsychopharmacol; 2004 Mar; 14(2):121-5. PubMed ID: 15013027
[TBL] [Abstract][Full Text] [Related]
9. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study.
Linnemann B; Janka HU
Exp Clin Endocrinol Diabetes; 2003 Jun; 111(4):215-22. PubMed ID: 12845560
[TBL] [Abstract][Full Text] [Related]
10. Heart rate-dependence of QTc intervals assessed by different correction methods in patients with normal or prolonged repolarization.
Chiladakis J; Kalogeropoulos A; Arvanitis P; Koutsogiannis N; Zagli F; Alexopoulos D
Pacing Clin Electrophysiol; 2010 May; 33(5):553-60. PubMed ID: 20025715
[TBL] [Abstract][Full Text] [Related]
11. [Prolonged QTc intervals in Parkinson's disease--relation to sudden death and autonomic dysfunction].
Ishizaki F; Harada T; Yoshinaga H; Nakayama T; Yamamura Y; Nakamura S
No To Shinkei; 1996 May; 48(5):443-8. PubMed ID: 8672303
[TBL] [Abstract][Full Text] [Related]
12. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
[TBL] [Abstract][Full Text] [Related]
13. QT interval prolongation in the patients receiving maintenance hemodialysis.
Suzuki R; Tsumura K; Inoue T; Kishimoto H; Morii H
Clin Nephrol; 1998 Apr; 49(4):240-4. PubMed ID: 9582555
[TBL] [Abstract][Full Text] [Related]
14. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function.
Rivera FA; Lapid MI; Sampson S; Mueller PS
J ECT; 2011 Sep; 27(3):207-13. PubMed ID: 21865957
[TBL] [Abstract][Full Text] [Related]
15. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.
Straus SM; Kors JA; De Bruin ML; van der Hooft CS; Hofman A; Heeringa J; Deckers JW; Kingma JH; Sturkenboom MC; Stricker BH; Witteman JC
J Am Coll Cardiol; 2006 Jan; 47(2):362-7. PubMed ID: 16412861
[TBL] [Abstract][Full Text] [Related]
16. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
17. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
18. Onsite QTc interval screening for patients in methadone maintenance treatment.
Fareed A; Vayalapalli S; Byrd-Sellers J; Casarella J; Drexler K; Amar R; Smith-Cox J; Lutchman TS
J Addict Dis; 2010 Jan; 29(1):15-22. PubMed ID: 20390695
[TBL] [Abstract][Full Text] [Related]
19. The impact of galantamine on cognition and mood during electroconvulsive therapy: a pilot study.
Matthews JD; Blais M; Park L; Welch C; Baity M; Murakami J; Sklarsky K; Homberger C; Fava M
J Psychiatr Res; 2008 Jun; 42(7):526-31. PubMed ID: 17681545
[TBL] [Abstract][Full Text] [Related]
20. QTc dispersion on the baseline ECG predicts arrhythmias during electroconvulsive therapy.
Rasmussen KG; Hooten WM; Dodd ML; Ryan DA
Acta Cardiol; 2007 Aug; 62(4):345-7. PubMed ID: 17824294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
